# Safety of Cotrimoxazole in HIV- and HAART-exposed Infants

> **NCT01086878** · PHASE4 · COMPLETED · sponsor: **Harvard School of Public Health (HSPH)** · enrollment: 222 (estimated)

## Conditions studied

- Acquired Immunodeficiency Syndrome
- Infant, Newborn
- Anemia
- Neutropenia
- HIV Infections

## Interventions

- **DRUG:** cotrimoxazole

## Key facts

- **NCT ID:** NCT01086878
- **Lead sponsor:** Harvard School of Public Health (HSPH)
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-02
- **Primary completion:** 2010-10
- **Final completion:** 2010-10
- **Target enrollment:** 222 (ESTIMATED)
- **Last updated:** 2011-02-25

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01086878

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01086878, "Safety of Cotrimoxazole in HIV- and HAART-exposed Infants". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT01086878. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*